72
Challenges in the Diagnosis of (Micro)Invasive Carcinoma Adriana Corben, MD Director Breast Pathology Fellowship

Challenges in the Diagnosis of (Micro)Invasive Carcinoma

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Challenges in the Diagnosis of

(Micro)Invasive Carcinoma

Adriana Corben, MD

Director Breast Pathology Fellowship

Page 2: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Overview

• Microinvasion

– Helpful clues

– Immunostains and pitfalls in interpretation

– Clinical significance

• Invasive ca that mimics benign

• Invasive ca that mimics in situ

• Benign that mimics invasive ca

Page 3: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Microinvasion

Page 4: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

2010 AJCC Staging Manual

• T1mi

• “Extension of cancer cells beyond the basement

membrane…as an invasive ca with no focus

measuring >1 mm”

• Not connected with CIS

• No need to subtype

• ‼ If multiple foci, should not be added together

• An attempt to quantify them should be included

• Prognosis is generally quite favorable

• Clinical impact of multifocality is not well understood

Page 5: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Always r/o microinvasion if…

• High grade or comedo-type DCIS

– Other DCIS types can also have it

• Comedo-type or pleomorphic LCIS

• Extensive CIS

• Periductal lymphoid infiltrates

• Mucocele-like lesions

Page 6: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful lower-power field tools

• Irregularity of the contour of the nests/glands

• Retraction around the invasive nests

• Tumor nests/glands without a lobulocentric

organization

• Chronic inflammation

• Reactive stroma

• Increased stromal cellularity

• DCIS: blurred edges of the duct wall due to

tangential sectioning

Page 7: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful higher-power field tools

• Irregularity of the contour of the nests/glands

• No basement membrane (BM): tumor cells

directly abut the stroma/adipose tissue

• No myoepithelial cells on H&E

• Retraction around the invasive nests

Page 8: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

•DCIS with

smooth contours

(below)

•Microinvasive

carcinoma with

irregular contours

(above)

Page 9: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 10: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC: absent lobular arrangement around benign

Page 11: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 12: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasion

Page 13: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

•Stromal (periductal)

chronic inflammation

needs closer

evaluation

•‼ Useful: at final

margins → levels!

Page 14: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive lobular carcinoma with lymphocytes

HMW-CK

Page 15: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Reactive stroma and increased stromal cellularity

Page 16: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Microinvasive lobular simulates lymphocytes

Page 17: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

DCIS: tangential

sectioning of the

duct wall will

create a blurred

edge

Page 18: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Helpful studies

• Definitive diagnosis is not always possible

on H&E

• ‼ Most useful adjunctive studies:

– IHC: at least 2 myoepithelial markers

Page 19: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Assessing invasion by IHC

• Invasive carcinoma:

– Lack of both basement membrane and

myoepithelial cells

• Benign and in situ lesions:

– Presence of both basement membrane and

myoepithelial cells

Page 20: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Myoepithelial cell markers

Marker Sensitivity Specificity

S-100 Good Unacceptable

Actin Good Poor

SMMHC Good Excellent

Calponin Excellent Very good

HMW-CK Very good Poor

Adapted from Yaziji, et al. Adv Anat Pathol 2000, 7:100-109

Page 21: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Calponin

Page 22: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Calponin: easily overlooked microinvasive carcinoma

Page 23: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

An H&E section

paired with 2

myoepithelial cell

markers is critical

Page 24: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MOST COMMONLY

USED

USED RARELY USED

CALPONIN CK5/6 S100

SMMHC CD10

SMA 34B12

p63

Page 25: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

p63

•p53 family

•Nuclei only

•High sensitivity

•High specificity

•No myofibroblast

staining

•Positive in some

DCIS and IDC

(metaplastic)

Page 26: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Tubular adenosis

Calponin

Page 27: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

SMMHC

Tubular adenosis

Page 28: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive tubular ca with SMA positive myofibroblasts

Page 29: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Myofibroblast cross-reactivity of

myoepithelial cell markers

SMA +++

Calponin ++

SMMHC +

p63 -

Page 30: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

A HMW-CK paired with 2 myoepithelial cell markers is critical

Page 31: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Lobular carcinoma

cells invade the

interlobular

collagenous stroma

Page 32: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Multinucleated stromal giant cells

Cytokeratin

Page 33: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clinical significance of

microinvasion

• Studies in the past:

– small numbers

– varying definitions

– varying degrees of tissue sampling

• No clear differences from pure DCIS

• Clinical significance is unclear

Page 34: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Single cells in the stroma:

what do they mean? De Mascarel, Cancer 2002; 94:2134

Page 35: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Axillary LN involvement

and 10 yrs outcome

De Mascarel, Cancer, 2002

#pts %node+

DCIS 722 1.4%

DCIS +

single cells

in stroma

72 0

DDFS OS

DCIS 98% 96.5%

DCIS +

single cells

in stroma

97% 96.3%

Page 36: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Single cells in the stroma:

what do they mean?

• No evidence that:

– Is associated with

axillary LN +

– Has adverse clinical

outcome

• In practice, we

consider them

microinvasion

• By using AJCC

definition pts will likely

have:

– Very low rate of ALNM

– Cure rate approaching

100% with good local

treatment

• Goal: identify this

subset of pts

Page 37: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive Carcinoma

that Mimics Benign

Page 38: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful clues

• Glandular disarray

• Irregular tubules/glands of variable

size/shape/orientation

• Infiltration around benign

• Open glandular lumina

• Lack of BM and myoepithelium

• Stromal hypercellularity

• Stromal desmoplasia

Page 39: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC mimicking benign adenosis

Page 40: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

SMMHC

Page 41: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive ductal carcinoma surrounding DCIS

Page 42: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive carcinoma within sclerosing adenosis

Page 43: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC mimics benign breast, but no BM and myoepithelium

Page 44: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Suspect ILC: Stromal hypercellularity and desmoplasia

Page 45: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive carcinoma

that mimics in situ

Page 46: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Problematic patterns

• Nested invasion

• Blunt invasion

• Occlusive LVI

Page 47: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for nested invasion

• Too confluent and/or haphazard

distribution

• Large nests adjacent to completely normal

lobules

• Irregularities in the contour of the nests

• Reactive stroma (if present)

• The following two pictures show how IDC

can mimic DCIS

Page 48: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 49: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for blunt invasion

• Common in solid papillary carcinoma and

papillary carcinoma

• Too large nests

• Discontinuity along the periphery of the

nests

• Fat, collagen, large vessels or benign

glands entrapped

Page 50: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Large size of

the nests

raises

concern of

blunt

invasion

Page 51: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Case initially misdiagnosed as DCIS

p63 SMA

Page 52: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC vs DCIS

Calponin

Page 53: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive Papillary Carcinoma

Page 54: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

p63

Page 55: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for occlusive LVI

• Buckshot distribution

• In arteries and veins

• Carcinoma associated with vascular

bundle

• D2-40 + and p63 –

• ‼ Issue: foci near margins

• The next 2 pictures show occlusive LVI

mimicking DCIS

Page 56: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 57: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

D2-40

• Ab to human

podoplanin

• Used to identify

lymphatic vessels

• Less myofibroblast

staining

• ‼ DCIS or LCIS with

retraction could be

misinterpreted as LVI

(and viceversa)

Page 58: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Benign lesions that mimic

invasive carcinoma

Page 59: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Sclerosing and pseudoinvasive

lesions

• Radial scar/complex sclerosing lesion

• Sclerosing adenosis

• Involvement of benign lesions by CIS

• Microglandular adenosis (MGA)

• Multinucleated stromal giant cells

• Mucocele-like lesions

• Sclerosing papillary lesions

Page 60: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Radial Scar Nidus

Page 61: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Tubular Carcinoma

Page 62: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Radial Scar Nidus

DCIS UDH

Page 63: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Sclerosing adenosis

Page 64: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

ALH in sclerosing

adenosis

Invasive lobular

carcinoma

Page 65: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

DCIS involving a sclerosing lesion

Calponin

Page 66: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA vs Tubular ca:

• Fibrotic stroma

• Uniform, round

tubules

• No snouts

• Eosinophilic colloid-

like secretion

• Prominent BM

• ER negative

• S100 positive

• ‼ Myoep negative

Page 67: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA reported associated with

ca in up to 25% of cases

• Rosenblum Am J Surg Pathol

1986;10:237

• James Am J Clin Pathol

1993;100:507

• Acs Am J Surg Pathol

2003;27:1052

• Resetkova Arch Pathol Lab

Med 2003;127:77

• Salarieh, Sneige Arch Pathol

Lab Med 2007;131:1397

AMGA

Page 68: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA and Carcinoma

•Similar immunoprofile

• ER -

• Myoeps -

• S100 +

•Overlapping genetic

alterations

•Suggested transition as a

non-obligate precursor

Shin S, et al. Am J Surg Pathol

2009;33;496

Page 69: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Recurrent issues with MGA

• Core biopsy

– Difficult to recognize

– Recommend excision

• Surgical specimen

– MGA at margin → complete excision

Page 70: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Artifactual displacement

Page 71: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Artifactual displacement

• Epithelium confined to

biopsy site

• Benign cytology with

round and “shrunken”

glands

• Benign primary lesion

• Myoepithelial cells may

or may not be retained

– More useful, if positive

– p63 more specific

Page 72: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Summary

• Microinvasion

– Helpful clues

– Immunostains and pitfalls in interpretation

– Clinical significance

• Invasive ca that mimics benign

• Invasive ca that mimics in situ

• Benign that mimics invasive ca